Bright Green (BGXX) Competitors $0.08 +0.01 (+12.97%) As of 01/17/2025 03:26 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BGXX vs. OMGA, CLNN, SRZN, BRNS, NBRV, ALRN, LTRN, ATNM, QTTB, and JATTShould you be buying Bright Green stock or one of its competitors? The main competitors of Bright Green include Omega Therapeutics (OMGA), Clene (CLNN), Surrozen (SRZN), Barinthus Biotherapeutics (BRNS), Nabriva Therapeutics (NBRV), Aileron Therapeutics (ALRN), Lantern Pharma (LTRN), Actinium Pharmaceuticals (ATNM), Q32 Bio (QTTB), and JATT Acquisition (JATT). These companies are all part of the "pharmaceutical products" industry. Bright Green vs. Omega Therapeutics Clene Surrozen Barinthus Biotherapeutics Nabriva Therapeutics Aileron Therapeutics Lantern Pharma Actinium Pharmaceuticals Q32 Bio JATT Acquisition Omega Therapeutics (NASDAQ:OMGA) and Bright Green (NASDAQ:BGXX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation. Which has more volatility and risk, OMGA or BGXX? Omega Therapeutics has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Comparatively, Bright Green has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Do insiders and institutionals believe in OMGA or BGXX? 97.5% of Omega Therapeutics shares are owned by institutional investors. Comparatively, 7.8% of Bright Green shares are owned by institutional investors. 8.5% of Omega Therapeutics shares are owned by insiders. Comparatively, 62.6% of Bright Green shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to OMGA or BGXX? In the previous week, Omega Therapeutics had 1 more articles in the media than Bright Green. MarketBeat recorded 1 mentions for Omega Therapeutics and 0 mentions for Bright Green. Omega Therapeutics' average media sentiment score of 0.59 beat Bright Green's score of 0.00 indicating that Omega Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Omega Therapeutics Positive Bright Green Neutral Does the MarketBeat Community favor OMGA or BGXX? Omega Therapeutics received 28 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformOmega TherapeuticsOutperform Votes2873.68% Underperform Votes1026.32% Bright GreenN/AN/A Which has preferable valuation and earnings, OMGA or BGXX? Bright Green has lower revenue, but higher earnings than Omega Therapeutics. Bright Green is trading at a lower price-to-earnings ratio than Omega Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmega Therapeutics$3.09M9.84-$97.43M-$1.33-0.41Bright GreenN/AN/A-$13.13M-$0.06-1.41 Do analysts rate OMGA or BGXX? Omega Therapeutics currently has a consensus price target of $9.20, suggesting a potential upside of 1,575.77%. Given Omega Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Omega Therapeutics is more favorable than Bright Green.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omega Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Bright Green 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is OMGA or BGXX more profitable? Bright Green has a net margin of 0.00% compared to Omega Therapeutics' net margin of -902.93%. Bright Green's return on equity of -88.37% beat Omega Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Omega Therapeutics-902.93% -213.13% -41.24% Bright Green N/A -88.37%-55.30% SummaryOmega Therapeutics beats Bright Green on 11 of the 16 factors compared between the two stocks. Get Bright Green News Delivered to You Automatically Sign up to receive the latest news and ratings for BGXX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGXX vs. The Competition Export to ExcelMetricBright GreenMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.15M$1.19B$5.36B$9.13BDividend YieldN/AN/A5.13%4.03%P/E Ratio-1.4134.6389.4717.33Price / SalesN/A5.661,261.53136.12Price / CashN/A9.9643.7535.97Price / Book1.412.045.324.80Net Income-$13.13M-$53.10M$122.60M$224.91M7 Day PerformanceN/A-1.14%0.69%1.77%1 Month PerformanceN/A-3.86%1.55%2.22%1 Year PerformanceN/A-8.56%27.25%20.67% Bright Green Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGXXBright GreenN/A$0.08+13.0%N/A-68.1%$16.15MN/A-1.412Gap DownOMGAOmega Therapeutics2.4835 of 5 stars$0.88+5.3%$9.20+940.3%-85.7%$46.51M$8.10M-0.66120High Trading VolumeCLNNClene2.5916 of 5 stars$5.55+3.9%$55.25+895.5%-50.7%$46.40M$421,000.00-1.05100SRZNSurrozen3.8963 of 5 stars$14.23-16.4%$45.00+216.2%+28.5%$46.25M$10M0.0042News CoveragePositive NewsBRNSBarinthus Biotherapeutics2.422 of 5 stars$1.14-3.4%$5.83+411.7%-69.0%$45.86M$14.97M-0.77107Short Interest ↑Analyst RevisionNews CoverageNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M-0.0770Analyst ForecastNews CoverageALRNAileron Therapeutics3.1412 of 5 stars$2.09-8.3%$19.00+809.1%N/A$45.28MN/A-0.679Short Interest ↑News CoverageLTRNLantern Pharma1.4378 of 5 stars$4.19+12.0%N/A-2.9%$45.19MN/A-2.3520News CoveragePositive NewsGap UpHigh Trading VolumeATNMActinium Pharmaceuticals1.2266 of 5 stars$1.43-0.7%$7.40+417.5%N/A$44.61M$81,000.00-1.0349QTTBQ32 Bio2.6675 of 5 stars$3.66-6.4%$29.86+715.8%N/A$44.58M$-6,651,000.00-0.2639Short Interest ↑JATTJATT AcquisitionN/A$2.58+9.8%N/A-49.0%$44.51MN/A0.003Gap UpHigh Trading Volume Related Companies and Tools Related Companies OMGA Alternatives CLNN Alternatives SRZN Alternatives BRNS Alternatives NBRV Alternatives ALRN Alternatives LTRN Alternatives ATNM Alternatives QTTB Alternatives JATT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGXX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Green Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Green With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
